Exosome Diagnostics
Cambridge, US · Delaware corporation · 1 known investors
BiotechHealthtech
Founders & leadership
WK
William KellyChief Financial Officer and Secretary of Issuer
TM
Thomas McLainChief Executive Officer and Director of Issuer
DK
Dhingra KapilNamed on SEC filing
SB
Sara BarringtonNamed on SEC filing
JM
James McCulloughNamed on SEC filing
Board
JB
Joseph BoystakBoard director
GM
SS
Steven SoignetBoard director
PJ
Peter JohannBoard director
KD
Kapil DhingraBoard director
JS
Joseph SlatteryBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$74.4M disclosed across 4 rounds · 2014–2017
▶$30.3MraisedJul 2017 · 43 investors · BiotechnologyRule 506(b)
▶$30.3MraisedJul 2017 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter JohannDirector
- Joseph SlatteryDirector
- Thomas McLainExecutive Officer
- Kapil DhingraDirector
- Steven SoignetDirector
- William KellyExecutive Officer
- Geert-Jan MulderDirector
- John BoyceExecutive Officer, Director
- Offering amount
- $30.3M
- Amount sold
- $30.3M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.5MraisedSep 2015 · 9 investors · BiotechnologyRule 506(b)
▶$15.5MraisedSep 2015 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter JohannDirector
- Joseph SlatteryDirector
- William KellyExecutive Officer
- Kapil DhingraDirector
- Steven SoignetDirector
- Geert-Jan MulderDirector
- Thomas McLainExecutive Officer, Director
- Amount sold
- $15.5M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedJul 2015 · 12 investors · Other Health CareRule 506(b)
▶$1.5MraisedJul 2015 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William KellyExecutive Officer
- Kapil DhingraDirector
- Joseph SlatteryDirector
- Joseph BoystakDirector
- Geert-Jan MulderDirector
- Thomas McLainExecutive Officer, Director
- Steven SoignetDirector
- Peter JohannDirector
- Offering amount
- $2.2M
- Amount sold
- $1.5M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.1MraisedMar 2014 · 26 investors · BiotechnologyRule 506(b)
▶$27.1MraisedMar 2014 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dhingra KapilDirector
- Joseph BoystakDirector
- Joseph SlatteryDirector
- Sara BarringtonExecutive Officer
- Peter JohannDirector
- Geert-Jan MulderDirector
- James McCulloughExecutive Officer, Director
- Offering amount
- $40M
- Amount sold
- $27.1M
- Sales commissions
- $897K
- Placement agents
- Leerink Partners LLC, Hudson Capital Advisors BD LLC
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Exosome Diagnostics's investors?
- Exosome Diagnostics's investors include Forbion.
- How much funding has Exosome Diagnostics raised?
- Exosome Diagnostics has disclosed $74.4M raised across 4 rounds.
- Where is Exosome Diagnostics headquartered?
- Exosome Diagnostics is headquartered in Cambridge, US.